Aloisi C - Search Results

1

Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients.

Buemi M, Allegra A, Laganà A, Aloisi C, Privitera M, Morabito N, Frisina N. Buemi M, et al. Among authors: aloisi c. Riv Eur Sci Med Farmacol. 1993 Sep-Dec;15(5-6):195-7. Riv Eur Sci Med Farmacol. 1993. PMID: 7761669 Clinical Trial.

2

Effects of intravenous administration of recombinant human erythropoietin in rats subject to hemorrhagic shock.

Buemi M, Allegra A, Squadrito F, Buemi AL, Laganà A, Aloisi C, Frisina N. Buemi M, et al. Among authors: aloisi c. Nephron. 1993;65(3):440-3. doi: 10.1159/000187526. Nephron. 1993. PMID: 8289996

3

[Rapid, progressive deterioration of renal function following erroneous administration of high doses of subcutaneous recombinant erythropoietin].

Buemi M, Allegra A, Aloisi C, Corica F, Frisina N. Buemi M, et al. Among authors: aloisi c. Riv Eur Sci Med Farmacol. 1996 Jan-Feb;18(1):39-42. Riv Eur Sci Med Farmacol. 1996. PMID: 8766781 Italian.

4

Rapid and transient lymphocytopenia after i.v. administration of high doses of human recombinant erythropoietin.

Buemi M, Allegra A, Corica F, Cavallaro G, Aloisi C, Pettinato G, Frisina N. Buemi M, et al. Among authors: aloisi c. Hematopathol Mol Hematol. 1997-1998;11(1):13-7. Hematopathol Mol Hematol. 1997. PMID: 9439976

5

Influence of therapy with recombinant erythropoietin on serum levels of neopterin in hemodialyzed subjects.

Buemi M, Allegra A, Aloisi C, Frisina N. Buemi M, et al. Among authors: aloisi c. Am J Nephrol. 1991;11(4):281-3. doi: 10.1159/000168322. Am J Nephrol. 1991. PMID: 1799185

6

[Amylasemia in uremics: a complex interpretation].

Buemi M, Molinaro M, Timpanelli R, Villari C, Conti C, Aloisi C, Morabito N, Venuto P, Frisina N. Buemi M, et al. Among authors: aloisi c. Riv Eur Sci Med Farmacol. 1994 Jan-Apr;16(1-2):21-5. Riv Eur Sci Med Farmacol. 1994. PMID: 7539150 Clinical Trial. Italian.

7

Recombinant human erythropoietin inhibits the cutaneous vasodilatation induced by acetylcholine.

Buemi M, Denuzzo G, Allegra A, Aloisi C, Squadrito F, Squadrito G, Dattola A, Corica F, Vermiglio G. Buemi M, et al. Among authors: aloisi c. Int J Microcirc Clin Exp. 1995 Nov-Dec;15(6):283-6. doi: 10.1159/000179076. Int J Microcirc Clin Exp. 1995. PMID: 8721436

8

Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock.

Allegra A, Galasso A, Siracusano L, Aloisi C, Corica F, Laganà A, Frisina N, Buemi M. Allegra A, et al. Among authors: aloisi c. Nephron. 1996;74(2):431-2. doi: 10.1159/000189352. Nephron. 1996. PMID: 8893173 Free article. No abstract available.

9

Hemodynamic effects of recombinant human erythropoietin.

Buemi M, Allegra A, Aloisi C, Corica F, Frisina N. Buemi M, et al. Among authors: aloisi c. Nephron. 1999 Jan;81(1):1-4. doi: 10.1159/000045238. Nephron. 1999. PMID: 9884412 Review. No abstract available.

10

Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration.

Buemi M, Allegra A, Corica F, Aloisi C, Ruello A, Giacobbe MS, Di Pasquale G, Senatore M, Frisina N. Buemi M, et al. Among authors: aloisi c. Am J Hypertens. 1999 Jan;12(1 Pt 1):73-5. doi: 10.1016/s0895-7061(98)00217-9. Am J Hypertens. 1999. PMID: 10075388 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters